Se connecter

Bibliographies thématiques / Hepatitis B-positive / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Hepatitis B-positive.

Articles de revues sur le sujet « Hepatitis B-positive »

Auteur : Grafiati

Publié le 2 juin 2025

Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Hepatitis B-positive ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Texte intégral

Résumé :

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

Styles APA, Harvard, Vancouver, ISO, etc.

2

O.W, Onwurah, Ajuba C.I, Nwoke C.G, and Anokwute M.U. "Prevalence of Hepatitis B e-Antigen among Hepatitis B positive subjects in Nnamdi Azikiwe University Teaching Hospital Nnewi." Journal of Clinical and Laboratory Research 3, no. 1 (2021): 01–04. http://dx.doi.org/10.31579/2768-0487/020.

Texte intégral

Résumé :

Hepatitis B virus (HBV) is a common cause of liver disease throughout the world. Cirrhosis, liver failure and hepatocellular carcinoma develop in 15–40% of chronically infected hepatitis B virus individuals. HBV is transmitted through blood and other body fluids, including semen and saliva. The aim of this study was to determine the prevalence of HBeAg amongst HBsAg positive subjects in Nnamdi Azikiwe University Teaching Hospital, Nnewi (NAUTH) . This study was a cross sectional study and data were collected through oral interview and questionnaire. Five milliliters of blood was collected asep

Styles APA, Harvard, Vancouver, ISO, etc.

3

Han, Zhenge, Yong Liu, Jinshun Pan, Yongchun Bi, Jingli Liu, and Yi-Hua Zhou. "Occult hepatitis B virus infection with positive hepatitis B e antigen." Clinica Chimica Acta 438 (January 2015): 266–68. http://dx.doi.org/10.1016/j.cca.2014.09.007.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Fitria, Liza, Hartono Gunardi, and Arwin A. P. Akib. "Influence of Hepatitis B immunization to prevent vertical transmission of Hep-B virus in infants bam from Hep-B positive mother." Paediatrica Indonesiana 50, no. 6 (2016): 321. http://dx.doi.org/10.14238/pi50.6.2010.321-5.

Texte intégral

Résumé :

Background Hepatitis B is one of the most common infectious diseases worldv.ide. Indonesia has moderate-high endemicity for hepatitis B infection. Perinatal transmission increases the risk for chronic hepatitis B. Infants from HBsAg-positive mothers should receive hepatitis B immunoglobulin (HBIG) and vaccination within 12 hours of birth, but this practice is not routinely done in Indonesia due to financial constraints.Objectives To detennine the influence of Hep-B immunization on preventing Hepatitis B vertical transmission. Methods A descriptive cohort study was conducted from May 2009 - Jan

Styles APA, Harvard, Vancouver, ISO, etc.

5

Waterson, A. P., June D. Almeida, Patricia M. Weeple, D. F. Hawkins, and Mary Cummins. "HEPATITIS B ANTIGEN-POSITIVE OBSTETRIC PATIENTS." BJOG: An International Journal of Obstetrics & Gynaecology 84, no. 9 (2008): 674–78. http://dx.doi.org/10.1111/j.1471-0528.1977.tb12679.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Beavers, Kimberly L. "TREATING HBeAg-POSITIVE CHRONIC HEPATITIS B." Evidence-Based Gastroenterology 4, no. 3 (2003): 114–15. http://dx.doi.org/10.1097/00132579-200308000-00015.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Shah, Niraj J., Elizabeth Paine, and Mary Burton. "3191 Two Cases of False Positive Hepatitis B Surface Antigen With Positive Hepatitis B E-Antigen." American Journal of Gastroenterology 114, no. 1 (2019): S1705. http://dx.doi.org/10.14309/01.ajg.0000602296.01002.64.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Schwarzwald, Heidi, and Nancy E. Kline. "False positive hepatitis B surface antigen test caused by hepatitis B vaccine." Pediatric Infectious Disease Journal 20, no. 11 (2001): 1101–2. http://dx.doi.org/10.1097/00006454-200111000-00027.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Feld, Jordan, and E. Heathcote. "Hepatitis B e Antigen-Positive Chronic Hepatitis B: Natural History and Treatment." Seminars in Liver Disease 26, no. 2 (2006): 116–29. http://dx.doi.org/10.1055/s-2006-939750.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Liaw, Yun-Fan, Sien-Sing Yang, Tong-Jong Chen, and Chia-Ming Chu. "Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis." Journal of Hepatology 1, no. 3 (1985): 227–33. http://dx.doi.org/10.1016/s0168-8278(85)80050-7.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Scuderi, V., A. Ceriello, W. Santaniello, et al. "Hepatitis B Prophylaxis in Hepatitis B–Negative Recipients Transplanted With Donor Grafts Positive for Hepatitis B Core Antibodies." Transplantation Proceedings 43, no. 1 (2011): 271–73. http://dx.doi.org/10.1016/j.transproceed.2010.09.100.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

Seto, Wai-Kay, Danny Ka-Ho Wong, James Fung, et al. "High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B." PLoS ONE 7, no. 8 (2012): e43087. http://dx.doi.org/10.1371/journal.pone.0043087.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

QUDDUSI, H., S. ANWAR, and M. S. AKHTER. "Pregnancy Outcome in Hepatitis B and C Positive Mothers." Annals of King Edward Medical University 11, no. 2 (2021): 134–36. https://doi.org/10.21649/akemu.v11i2.4281.

Texte intégral

Résumé :

Aims: To see frequency of hepatitis B and C in pregnant patient and the pregnancy outcome in hepatitis B and C positive mothers. Study design: descriptive study. Setting: This study was conducted in Gynae unit III and labour ward Nisbter hospital Multan from Jan 04 to Mar 05 in collaboration with Central Laboratory in our hospital. Material and methods: All pregnant patients admitted through OPD and labour ward who were found hepatitis B and C positive during screening were included in this study. Patient with chronic liver disease, cirrhosis and acute hepatitis due to A and E virus were exclu

Styles APA, Harvard, Vancouver, ISO, etc.

14

Shrivastava, Shikha, Nirupama TrehanPati, Shyam Kottilil, and Shiv Kumar Sarin. "Decline in Immature Transitional B Cells After Hepatitis B Vaccination in Hepatitis B Positive Newborns." Pediatric Infectious Disease Journal 32, no. 7 (2013): 792–94. http://dx.doi.org/10.1097/inf.0b013e31828df344.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

Anjum, Muhammad Usman, Muhammad Safdar Khan, Nazar Muhamamd Afridi, and Syed Humayun Shah. "HEPATITIS B AND C VIRUS INFECTIONS." Professional Medical Journal 22, no. 10 (2015): 1284–88. http://dx.doi.org/10.29309/tpmj/2015.22.10.981.

Texte intégral

Résumé :

Patients with end stage renal disease require haemodialysis as a part of theirtreatment. The incidence of hepatitis B and C virus infection is quite high in patients undergoingmaintenance haemodialysis than in general population. This risk is specifically associatedwith use of blood and its products as well as repeated intravascular access in these patients.Objectives: To determine the seropositivity of hepatitis B and C virus infection in patientsreceiving haemodialysis. Design: Descriptive cross sectional study. Setting: NephrologyDepartment, Ayub Teaching Hospital, Abbottabad, Pakistan. Per

Styles APA, Harvard, Vancouver, ISO, etc.

16

Jyoti, Ranjan Behera, Ranjan Mallick Manas, Kumar Jena Sanjaya, Ranjan Barik Rashmi, Roy Debashisha, and Kumar Mohanty Anil. "Efficacy of Hepatitis B Immunoglobulin and Hepatitis B Vaccine in Prevention of Perinatal Transmission of Hepatitis B." International Journal of Pharmaceutical and Clinical Research 15, no. 11 (2023): 232–38. https://doi.org/10.5281/zenodo.11214130.

Texte intégral

Résumé :

<strong>Introduction: </strong>Hepatitis B is a major global health problem and is a most serious type of viral hepatitis, which puts the people at high risk of death from cirrhosis of the liver and liver cancer. Approximately 30% of the world’s population, or about 2 billion persons, have serological evidence of either current or past infection with hepatitis B virus. Most people in China and India become infected with HBV during childhood. India has intermediate endemicity of Hepatitis B, with Hepatitis B surface antigen (HBsAg) prevalence between 2% and 7% among populations studi

Styles APA, Harvard, Vancouver, ISO, etc.

17

Lobello, S., U. Lorenzoni, A. Vian, A. Floreani, M. R. Brunetto, and M. Chiaramonte. "Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring." Journal of Viral Hepatitis 5, no. 1 (1998): 61–66. http://dx.doi.org/10.1046/j.1365-2893.1998.00083.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Lin, W. T., Y. M. Chen, D. Y. Chen, et al. "Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study." Lupus 27, no. 1 (2017): 66–75. http://dx.doi.org/10.1177/0961203317711009.

Texte intégral

Résumé :

Objective We aimed to investigate risk of hepatitis B virus reactivation in systemic lupus erythematosus patients with different hepatitis B virus infection statuses receiving immunosuppressive therapy. Methods We retrospectively analyzed systemic lupus erythematosus patients with positive hepatitis B surface antigen or anti-hepatitis B core IgG antibody who underwent immunosuppressive therapies from January 2001 to December 2012 at a medical center in Taiwan for evidence of hepatitis B virus reactivation. Results During this period, 906 out of 3125 patients who were diagnosed with systemic lu

Styles APA, Harvard, Vancouver, ISO, etc.

19

Franchello, Alessandro, Valeria Ghisetti, Alfredo Marzano, Renato Romagnoli, and Mauro Salizzoni. "Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection." Liver Transplantation 11, no. 8 (2005): 922–28. http://dx.doi.org/10.1002/lt.20471.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Thornton, Alicia C., Sophie Jose, Sanjay Bhagani, et al. "Hepatitis B, hepatitis C, and mortality among HIV-positive individuals." AIDS 31, no. 18 (2017): 2525–32. http://dx.doi.org/10.1097/qad.0000000000001646.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Kim, Kyeongdeok, Manuel Lim, Jieun Kwon, et al. "HEPATITIS B IMMUNOGLOBULIN PROPHYLAXIS FOR PREVENTION OF DE NOVO HEPATITIS B INFECTION FROM HEPATITIS B CORE ANTIBODY-POSITIVE DONORS." Transplantation 104, S3 (2020): S527. http://dx.doi.org/10.1097/01.tp.0000701348.41608.48.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Kim, Kyeongdeok, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, and Jae-Won Joh. "Hepatitis B immunoglobulin prophylaxis for prevention of de novo Hepatitis B infection from hepatitis B core antibody-positive donors." Journal of Hepatology 73 (August 2020): S266—S267. http://dx.doi.org/10.1016/s0168-8278(20)31036-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Nguyen, Mindie H., and Emmet B. Keeffe. "Editorial Commentary:Are Hepatitis B e Antigen (HBeAg)–Positive Chronic Hepatitis B and HBeAg‐Negative Chronic Hepatitis B Distinct Diseases?" Clinical Infectious Diseases 47, no. 10 (2008): 1312–14. http://dx.doi.org/10.1086/592571.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Pilmore, Helen L., and Edward J. Gane. "Hepatitis B–Positive Donors in Renal Transplantation." Transplantation Journal 94, no. 3 (2012): 205–10. http://dx.doi.org/10.1097/tp.0b013e31824e3db4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

Rosen, Les B., Arkadi M. Rywlin, and Lionel Resnick. "Hepatitis B surface antigen positive skin lesions." American Journal of Dermatopathology 7, no. 6 (1985): 507–14. http://dx.doi.org/10.1097/00000372-198512000-00002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Veroux, M., C. Puliatti, M. Macarone, et al. "Kidney Transplantation From Hepatitis B Surface Antigen–Positive Donors Into Hepatitis B Surface Antigen–Positive Recipients: Preliminary Findings." Transplantation Proceedings 37, no. 6 (2005): 2467–68. http://dx.doi.org/10.1016/j.transproceed.2005.06.011.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Veroux, M., C. Puliatti, M. Gagliano, et al. "Use of Hepatitis B Core Antibody-Positive Donor Kidneys in Hepatitis B Surface Antibody-Positive and -Negative Recipients." Transplantation Proceedings 37, no. 6 (2005): 2574–75. http://dx.doi.org/10.1016/j.transproceed.2005.06.068.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Fan, Rong, Jie Peng, Qing Xie, et al. "Combining Hepatitis B Virus RNA and Hepatitis B Core–Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen–Positive Patients With Chronic Hepatitis B." Journal of Infectious Diseases 222, no. 4 (2020): 611–18. http://dx.doi.org/10.1093/infdis/jiaa136.

Texte intégral

Résumé :

Abstract Background Safe nucleos(t)ide analogue discontinuation in chronic hepatitis B (CHB) is an unmet need. We aimed to investigate whether combining hepatitis B virus (HBV) RNA and hepatitis B core–related antigen (HBcrAg) could perform satisfactorily in predicting off-treatment outcomes. Methods The evaluation cohort included 127 hepatitis B e antigen (HBeAg)–positive patients from a multicenter prospective trial who stopped telbivudine-based therapy after achieving HBeAg seroconversion and HBV DNA &lt; 50 IU/mL for &gt; 48 weeks. As validation, 59 patients treated with entecavir

Styles APA, Harvard, Vancouver, ISO, etc.

29

Cramp, M. E., H. C. Grundy, R. M. Perinpanayagam, and D. E. Barnado. "Seroprevalence of Hepatitis B and C Virus in Two Institutions Caring for Mentally Handicapped Adults." Journal of the Royal Society of Medicine 89, no. 7 (1996): 401–2. http://dx.doi.org/10.1177/014107689608900712.

Texte intégral

Résumé :

Hepatitis B virus infection is common in institutions caring for the mentally handicapped. Hepatitis B virus and hepatitis C virus share routes of transmission but the prevalence of hepatitis C virus infection in this population is unknown. We have tested 101 patients from two institutions in South-East England caring for adults with mental handicap for the presence of hepatitis C antibody, hepatitis B core antibody, and if necessary hepatitis B surface antigen. None tested positive for hepatitis C antibody, but 43 had hepatitis B core antibody of whom 14 were chronic carriers positive for hep

Styles APA, Harvard, Vancouver, ISO, etc.

30

Borojevic, Branko, Ayushi Chauhan, and Scott Patterson. "Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma." BMJ Case Reports 14, no. 7 (2021): e243526. http://dx.doi.org/10.1136/bcr-2021-243526.

Texte intégral

Résumé :

A 93-year-old man was admitted with 1 week of frank jaundice and abdominal pain. His medical history included diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, hydroxydaunomycin, oncovin and prednisolone (R-CHOP) chemotherapy 10 months prior. His investigations revealed marked hyperbilirubinemia with a total bilirubin of 355 μmol/L, along with a 17-fold elevation in alanine transaminase and impaired hepatic synthetic function. He tested hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (HBsAb) negative, hepatitis B core antibody (HBcAb) positive and

Styles APA, Harvard, Vancouver, ISO, etc.

31

Yang, Shu-Sheng, Fei Fu, Qian-Kun Xuan, et al. "Hepatitis B surface antigen-negative but hepatitis B envelope antigen-positive false occult hepatitis B virus infection: A case report." World Journal of Hepatology 16, no. 10 (2024): 1379–87. http://dx.doi.org/10.4254/wjh.v16.i10.1379.

Texte intégral

Résumé :

BACKGROUND Occult hepatitis B infection (OBI) is characterized by the detection of hepatitis B virus (HBV) DNA in serum (usually HBV DNA < 200 IU/mL) or the liver but negativity for hepatitis B surface antigen (HBsAg). The diagnosis of OBI relies on the sensitivity of assays used in the detection of HBV DNA and HBsAg. HBsAg assays with inadequate sensitivity or inability to detect HBV S variants may lead to misdiagnosis of OBI in people with overt HBV infection. CASE SUMMARY We report a HBsAg-negative but hepatitis B envelope antigen-positive patient who had a significant HBV DNA level. The

Styles APA, Harvard, Vancouver, ISO, etc.

32

Yang, Shu-Sheng, Fei Fu, Qian-Kun Xuan, et al. "Hepatitis B surface antigen-negative but hepatitis B envelope antigen-positive false occult hepatitis B virus infection: A case report." World Journal of Hepatology 16, no. 10 (2024): 1199–207. http://dx.doi.org/10.4254/wjh.v16.i10.1199.

Texte intégral

Résumé :

BACKGROUND Occult hepatitis B infection (OBI) is characterized by the detection of hepatitis B virus (HBV) DNA in serum (usually HBV DNA < 200 IU/mL) or the liver but negativity for hepatitis B surface antigen (HBsAg). The diagnosis of OBI relies on the sensitivity of assays used in the detection of HBV DNA and HBsAg. HBsAg assays with inadequate sensitivity or inability to detect HBV S variants may lead to misdiagnosis of OBI in people with overt HBV infection. CASE SUMMARY We report a HBsAg-negative but hepatitis B envelope antigen-positive patient who had a significant HBV DNA level. The

Styles APA, Harvard, Vancouver, ISO, etc.

33

Hanbali, Amr, Yasser Khaled, Hussein Ajrouche, Shan Ansari, and Nalini Janakiraman. "Incidence of Hepatitis B Reactivation in Association with Rituximab Therapy." Blood 108, no. 11 (2006): 2766. http://dx.doi.org/10.1182/blood.v108.11.2766.2766.

Texte intégral

Résumé :

Abstract Introduction: Hepatitis B reactivation and fulminant acute hepatitis has been described in association with Rituximab therapy. However, the incidence of these adverse effects is unknown and there are no established guidelines for hepatitis B screening prior to Rituximab therapy. Method: To study the incidence of hepatitis B reactivation in association with Rituximab, we reviewed the records of 456 patients treated with Rituximab between 1998 and 2004. We identified 32 patients with positive hepatitis B serology who received Rituximab alone (#14) or with chemotherapy (#18) for NHL (n#1

Styles APA, Harvard, Vancouver, ISO, etc.

34

ter Borg, Martijn J., та Harry L. A. Janssen. "Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B". Annals of Internal Medicine 143, № 5 (2005): 391. http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00018.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Chan, Henry L. Y., та Joseph J. Y. Sung. "Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B". Annals of Internal Medicine 143, № 5 (2005): 391. http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00019.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Uemoto, S., Y. Inomata, A. Sannomiya, et al. "Posttransplant Hepatitis B Infection in Liver Transplantation With Hepatitis B Core Antibody-Positive Donors." Transplantation Proceedings 30, no. 1 (1998): 134–35. http://dx.doi.org/10.1016/s0041-1345(97)01211-6.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

37

Marcellin, Patrick, Ting-Tsung Chang, Seng Gee Lim, et al. "Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B." New England Journal of Medicine 348, no. 9 (2003): 808–16. http://dx.doi.org/10.1056/nejmoa020681.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Bonino, Ferruccio, and Maurizia Rossana Brunetto. "Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview." Journal of Hepatology 39 (January 2003): 160–63. http://dx.doi.org/10.1016/s0168-8278(03)00319-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Cooksley, Graham. "The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon." Journal of Hepatology 39 (January 2003): 143–45. http://dx.doi.org/10.1016/s0168-8278(03)00327-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

40

Lao, Terence T., K. L. Cheung, and Vincent Wong. "Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women." Vaccine 33, no. 1 (2015): 15–16. http://dx.doi.org/10.1016/j.vaccine.2014.05.036.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Ko, Stephen C., Sarah F. Schillie, Tanja Walker, et al. "Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women." Vaccine 32, no. 18 (2014): 2127–33. http://dx.doi.org/10.1016/j.vaccine.2014.01.099.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

42

Tur-Kaspa, R., M. Braun, and Z. Ben-Ari. "HEPATITIS B CORE ANTIBODY-POSITIVE LIVER RECIPIENTS AND HEPATITIS B REACTIVATION AFTER LIVER TRANSPLANTATION." Transplantation 73, no. 3 (2002): 331–32. http://dx.doi.org/10.1097/00007890-200202150-00002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Phinius, Bonolo B., Motswedi Anderson, Margaret Mokomane, et al. "Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana." Viruses 15, no. 7 (2023): 1544. http://dx.doi.org/10.3390/v15071544.

Texte intégral

Résumé :

(1) Background: Hepatitis B core antibodies (anti-HBc) are a marker of hepatitis B virus (HBV) exposure; hence, a normal HBV serology profile is characterized by HBV surface antigen (HBsAg) and anti-HBc positivity. However, atypical HBV serologies occur, and we aimed to determine the prevalence of an atypical profile (HBsAg+/anti-HBc-) in a cohort of people with HIV-1 (PWH) in Botswana. (2) Methods: Plasma samples from an HIV-1 cohort in Botswana (2013–2018) were used. The samples were screened for HBsAg and anti-HBc. Next-generation sequencing was performed using the GridION platform. The Wil

Styles APA, Harvard, Vancouver, ISO, etc.

44

Tassopoulos, Nicolaos C., Riccardo Volpes, Giuseppe Pastore, et al. "Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis BB." Hepatology 29, no. 3 (1999): 889–96. http://dx.doi.org/10.1002/hep.510290321.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

Janzen, L., G. Y. Minuk, M. Fast, and K. N. Bernstein. "Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data." Journal of the American Society of Nephrology 7, no. 8 (1996): 1228–34. http://dx.doi.org/10.1681/asn.v781228.

Texte intégral

Résumé :

This report describes hepatitis B vaccinations that resulted in transient hepatitis B surface antigen positivity in six adult hemodialysis patients. Initially, three patients were incidentally discovered to be hepatitis B surface antigen-positive temporally related to hepatitis B vaccination. Two other patients who displayed transient positivity were among 15 hemodialysis patients under prospective surveillance after receiving a dose of hepatitis B vaccine. The sixth patient was negative for hepatitis B surface antigen when monitored in the prospective surveillance group but was incidentally f

Styles APA, Harvard, Vancouver, ISO, etc.

46

Aghayeva, S. Сh, and A. A. Hidayatov. "THE IMPACT OF OCCULT HEPATITIS B INFECTION ON THE COURSE OF CHRONIC HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 22, no. 1 (2022): 4–8. http://dx.doi.org/10.31718/2077-1096.22.1.4.

Texte intégral

Résumé :

The prevalence of viral hepatitis B and C in Azerbaijan is 3.2% and 4.3% respectively. The incidence of occult hepatitis B has not been previously studied. The purpose of this study is to assess the prevalence of occult hepatitis B infection among patients with chronic hepatitis C, as well as to assess the impact of occult hepatitis B on the progression of liver disease and to identify the likelihood of viral/clinical reactivation of occult hepatitis B during treatment with direct-acting antiviral drugs. Results. The study included 164 patients with chronic hepatitis C with the absence of over

Styles APA, Harvard, Vancouver, ISO, etc.

47

Chonco, F. M., and S. Rangiah. "Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa." South African Family Practice 61, no. 2 (2019): 51. http://dx.doi.org/10.4102/safp.v61i2.5004.

Texte intégral

Résumé :

Background: HIV/HBV co-infection remains a global threat to HIV management despite the available effective hepatitis B vaccine and hepatitis B covering antiretroviral therapy. Many studies done in South Africa and internationally showed high prevalence of HIV/hepatitis B co-infection, which mandated routine screening for both infections before initiating HAART. Fewer studies have highlighted the prevalence of hepatitis B susceptibility in the general population starting HAART and most of them were limited to children and high-risk groups. The aim of this study was to demonstrate the extent of

Styles APA, Harvard, Vancouver, ISO, etc.

48

Sonneveld, Milan J., Bettina E. Hansen, Teerha Piratvisuth, et al. "Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels." Hepatology 58, no. 3 (2013): 872–80. http://dx.doi.org/10.1002/hep.26436.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

49

Ocan, Moses, Frances Acheng, Carol Otike, Judith Beinomugisha, David Katete, and Celestino Obua. "Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda." PLOS ONE 17, no. 1 (2022): e0262126. http://dx.doi.org/10.1371/journal.pone.0262126.

Texte intégral

Résumé :

Hepatitis B vaccine has contributed to the reduction in hepatitis B virus infections and chronic disease globally. Screening to establish extent of vaccine induced immune response and provision of booster dose are limited in most low-and-middle income countries (LMICs). Our study investigated the extent of protective immune response and breakthrough hepatitis B virus infections among adult vaccinated healthcare workers in selected health facilities in northern Uganda. A cross-sectional study was conducted among 300 randomly selected adult hepatitis B vaccinated healthcare workers in Lira and G

Styles APA, Harvard, Vancouver, ISO, etc.

50

Mas, Antoni, María Buti, Rafael Esteban, et al. "Hepatitis B virus and hepatitis D virus replication in HBsAg-positive fulminant hepatitis." Hepatology 11, no. 6 (1990): 1062–65. http://dx.doi.org/10.1002/hep.1840110624.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!